Pharmaceutical Mail. The Boehringer Ingelheim and Lilly diabetes alliance announces the launch in Spain of its insulin glargine abasaglar, biosimilar of lantus, from Sanofi. This basal insulin, the first biosimilar to be sold in Spain, is presented in a pre-filled pen Kwik Pen.